Eizaburo Sasatomi, MD, PhD
Assistant Professor of Pathology

Dr. Sasatomi is a member of the Division of Transplantation Pathology. He is one of the Presenters of the weekly Liver Tumor Board Conference and a Member and COE Leader for Division of Transplantation Pathology of the Professional Quality Assurance Committee, March 2008-present.
Office Location:
Room E-734
UPMC Montefiore Hospital
3459 5th Avenue
Pittsburgh, PA 15213
Contact Information:
Office Telephone: 412-864-3970
Fax: 412-647-5237
Email: sasatomie@upmc.edu


  • MD, Saga Medical School, Saga, Japan, 1989
  • Ph.D. Saga Medical School, Saga, Japan, 1997


  • Japanese Medical License Registration - 1989
  • Pennsylvania Medical License (Graduate Medical Trainee) - 2003
  • Pennsylvania Medical License (Medical Physician and Surgeon) - 2006

Awards and Honors

  • First prize in Pulmonary Pathology Society Award for Best Presentation at the United States and Canadian Academy Of Pathology (USCAP) Meeting - 2001
  • Best Autopsy Performance Award, Department of Pathology, University of Pittsburgh Medical Center - 2004

Clinical Experties

Pathologic evaluation of native, donor and allograft liver, kidney and heart, allograft small intestine pancreas and consult cases.

Research Experties

Dr. Sasatomi's primary interest is in hepatobiliary pathology and transplant pathology. Dr. Sasatomi's research interest includes molecular genetics of hepatobiliary carcinogenesis.

Selected Publications

View Dr. Sasatomi's publications on PubMed

Castillo-Rama M, Sebagh M, Sasatomi E, Randhawa P, Isse K, Salgarkar AD, Ruppert K, Humar A, Demetris AJ: "Plasma cell hepatitis" in liver allografts: identification and characterization of an IgG4-rich cohort. Am J Transplant. 2013 Nov;13(11):2966-77.

Sasatomi E, Nalesnik MA, Marsh JW: Neuroendocrine carcinoma of the extrahepatic bile duct: case report and literature review. World J Gastroenterol. 2013 Jul 28;19(28):4616-23.

Cruz RJ Jr, Ramachandra S, Sasatomi E, DiMartini A, de Vera M, Fontes P, Hughes C, Humar A: Surgical management of gastrointestinal posttransplant lymphoproliferative disorders in liver transplant recipients. Transplantation. 2012 Aug 27;94(4):417-23.

Hartman D, Krasinskas AM, Sasatomi E: Caveat emptor: submitting the entire gallbladder in cases of dysplasia is not justified. Am J Clin Pathol. 2013 Jun;139(6):830.

Adeyi O, Alexander G, Baiocchi L, Balasubramanian M, Batal I, O C BC, Bhan A, Bridges N, Bucuvalas J, Charlotte F, Colvin B, Czaja A, Demetris A, Devera M, S EM, Feng S, Ferrell L, Fiel Maria I, Fontes P, Fung J, Haga H, Hart J, Honsova E, Hubscher S, Wesam I, Itoh T, Jhala N, Jungmann P, Khettry U, Koshiba T, Lassman C, Lerut J, Ligato S, Lunz J, Mazariegos G, McCaughan G, A MS, I MM, Misdraji J, Mohanakumar T, Molne J, Musat A, Nalesnik M, Nasser I, Neil D, Neuberger J, Pappo O, Petrovic L, Randhawa P, P RF, Rubin E, Ruiz P, Sagol O, Sanchez F, Sasatomi E, Schiano T, Sebagh M, Shaked A, Sharkey Francis E, Shimizu T, Sis B, Smith M, Sonzogni A, Tchao N, Thung S, Tisone G, Tsamandas A, Wernerson A, Wu T, Yilmaz F; The Banff Working Group on Liver Allograft Pathology. Importance of liver biopsy findings in immunosuppression management: Biopsy monitoring and working criteria for patients with operational tolerance (OT). Liver Transpl. Oct;18(10):1154-70, 2012.

Lunz J, Ruppert KM, Cajaiba MM, Isse K, Bentlejewski CA, Minervini M, Nalesnik MA, Randhawa P, Rubin E, Sasatomi E, de Vera ME, Fontes P, Humar A, Zeevi A, Demetris AJ. Re-examination of the lymphocytotoxic crossmatch in liver transplantation: can C4d stains help in monitoring? Am J Transplant. 2012 Jan;12(1):171-82.

Batal I, Azzi J, El-Haddad N, Riella LV, Lunz JG 3rd, Zeevi A, Sasatomi E, Basu A, Tan H, Shapiro R, Randhawa P. Immunohistochemical markers of tissue injury in biopsies with transplant glomerulitis. Hum Pathol. 2012 Jan;43(1):69-80.

Sasatomi E, Johnson LR, Aldeeb DN, Lomago DM, Thompson JW Jr, Swalsky PA, Luketich JD, Fernando HC, Finkelstein SD, Yousem SA. Genetic profile of cumulative mutational damage associated with early pulmonary adenocarcinoma: bronchioloalveolar carcinoma vs. stage I invasive adenocarcinoma. Am J Surg Pathol. 2004 Oct;28(10):1280-8.

Sasatomi E, Finkelstein SD, Woods JD, Bakker A, Swalsky PA, Luketich JD, Fernando HC, Yousem SA. Comparison of accumulated allele loss between primary tumor and lymph node metastasis in stage II non-small cell lung carcinoma: implications for the timing of lymph node metastasis and prognostic value. Cancer Res. 2002 May 1;62(9):2681-9.

Sasatomi E, Tokunaga O, Miyazaki K. Precancerous conditions of gallbladder carcinoma: overview of histopathologic characteristics and molecular genetic findings. J Hepatobiliary Pancreat Surg. 2000;7(6):556-67. Review.

Sasatomi E, Tokunaga O, Miyazaki K. Spontaneous apoptosis in gallbladder carcinoma. Relationships with clinicopathologic factors, expression of E-cadherin, bcl-2 protooncogene, and p53 oncosuppressor gene. Cancer. 1996 Nov 15;78(10):2101-10.